Skip to main content
. 2025 May 28;25:962. doi: 10.1186/s12885-025-14374-8

Table 5.

Molecular type of patients with BC according to St. Gallen conference in 2011

Molecular type Death (n) Survive (n) Total (n) median Ki-67 index (%) χ2 P
Luminal A 9 51 60 7.52%
Luminal B HER-2 (-) 13 57 70 27.41%
Luminal B HER-2 (+) 9 33 42 23.84%
Over-expression HER-2 15 28 43 31.10% 5.33 0.021
Triple-negative 12 27 39 35.32% 3.36 0.067*

Luminal A type vs.HER-2 over-expression type; * Luminal A type vs. triple negative type